Oculis announces agreement with US FDA on a Special Protocol Assessment for optic neuritis registrational trial: Zug, Switzerland Saturday, May 9, 2026, 11:00 Hrs [IST] Oculis Hol ...

Hidden inflammation and later trouble, says study by Karl Landsteiner University: Krems, Austria Saturday, May 9, 2026, 10:00 Hrs [IST] A new study suggests that ...

Angelini Pharma to acquire Catalyst for 4.1 billion; entering US market and consolidating its leadership in brain health & rare disease: Rome Saturday, May 9, 2026, 09:00 Hrs [IST ...

Experts have informed that the Indian pharma has moved from volume-led generics to value plus innovation-led growth through strategic mergers and acquisitions (M&As) over the past one year. The ...

Rift deepens in Assam pharma trade as ADDA refuses to join nationwide pharmacy bandh: Peethaambaran Kunnathoor, Chennai Saturday, May 9, 2026, 08:00 Hrs [IST] The pharmaceutical t ...

The Parliamentary Panel on Health and Family Welfare has recommended to the Ministry of Ayush to create a dedicated Ayush Infrastructure Fund with multi-year capital option for institutional ...

Pharmacy institutes stress on PM Internship Scheme for hands-on training and better employability: Nandita Vijayasimha, Bengaluru Saturday, May 9, 2026, 08:00 Hrs [IST] Pharmacy c ...

Indian hospitals note early referral to specialized care centers could spot hemophilia early before it becomes a medical emergency. In India and globally, hemophilia remains undiagnosed or ...

PCI announces extended timeline for approval process during AY 2026-27: Gireesh Babu, New Delhi Saturday, May 9, 2026, 08:00 ...

Symeres appoints Henning Steinhagen as CEO to drive next phase of strategic growth: Nijmegen, Netherlands Friday, May 8, 2026, 18:00 Hrs [IST] Symeres, a leading transatlantic con ...

NIH-funded study suggests that testosterone suppresses brain tumour growth in males: Bethesda, Maryland Friday, May 8, 2026, 17:00 Hrs [IST] In a new National Institutes of Health ...

Bayer announced positive topline results from the phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital that evaluated the investigational PET/CT radiotracer I 124 ...